Cellsight Technologies, Inc.
San Francisco, CA Doing business as Cellsight Technologies Inc.
- UEI
- E3UQXACGFR43
- CAGE
- 5T0V1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 185 Berry St #350, San Francisco, CA 94107, USA
- Website
- cellsighttech.com
- Founded
- 2009
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Imaging intracerebral and systemic t cell immunity in patients with alzheimer's disease using 18F-f-arag - project… | National Institute on Aging | $1,754,182 | |
| Sbir phase II - topic 396 - imaging for cancer immunotherapies | National Cancer Institute | $1,995,174 | |
| Sbir phase i topic 396 evaluation of [18F]f-arag, a t cell-specific pet agent, as an imaging biomarker predictive of… | National Cancer Institute | $300,000 | |
| Sbir topic 376: a noninvasive pet imaging strategy for longitudinal monitoring of immune contexture in the tumor… | National Cancer Institute | $299,641 | |
| Monitoring immune response to immunotherapies in cancer patients with visact pet tracer | National Cancer Institute | $2,040,978 |
About Cellsight Technologies, Inc.
Cellsight Technologies, Inc. is a molecular imaging company based in San Francisco, California, registered as a woman-owned small business in the System for Award Management (SAM) since 2009. The company specializes in developing advanced PET imaging agents and provides technical support and research services primarily focused on medical imaging technologies for cancer and neurodegenerative disease applications. As a for-profit organization, Cellsight Technologies leverages its expertise in molecular imaging to support federal research initiatives through contract and grant awards.
Through its federal contract awards, Cellsight Technologies has been awarded a Small Business Innovation Research (SBIR) Phase II contract from the National Cancer Institute (NCI) valued at $1,995,174. The contract focuses on developing the [18F]F-ARAG imaging agent to quantitatively assess response to immunotherapy in non-small cell lung cancer. The contract is set aside for small businesses and is structured as a definitive contract with a completion date of September 15, 2026. This award builds upon a previous $300,000 SBIR Phase I contract and demonstrates the company's capability to advance innovative medical imaging technologies for cancer research.
In terms of federal grant awards, Cellsight Technologies has received a substantial Project Grant from the National Institute on Aging totaling $871,261, aimed at investigating the use of the PET imaging agent [18F]F-ARAG as a biomarker for detecting T cell activity in Alzheimer's disease patients. Additionally, the company has been involved in multiple sub-grant awards, including collaborative projects with the University of California, San Francisco, focused on imaging cardiac toxicity associated with cancer therapies. These sub-awards involve providing technical support, precursor materials, and expertise in analyzing and interpreting research results related to [18F]F-ARAG's applications in monitoring immune responses and potential cardiotoxicity in cancer treatments.
Quick answers
What is Cellsight Technologies, Inc.'s UEI?
Cellsight Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is E3UQXACGFR43.
What is Cellsight Technologies, Inc.'s CAGE code?
Cellsight Technologies, Inc.'s CAGE code is 5T0V1.
What is Cellsight Technologies, Inc.'s primary NAICS code?
Cellsight Technologies, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cellsight Technologies, Inc. located?
Cellsight Technologies, Inc.'s physical address in SAM.gov is 185 Berry St #350, San Francisco, CA 94107, USA.
Is Cellsight Technologies, Inc. registered in SAM.gov?
Yes. Cellsight Technologies, Inc.'s SAM.gov registration is active through August 25, 2027.
What is Cellsight Technologies, Inc.'s most recent federal award?
Cellsight Technologies, Inc.'s most recent federal grant award is Imaging intracerebral and systemic t cell immunity in patients with alzheimer's disease using 18F-f-arag - project… (R44AG094397), from National Institute on Aging, on September 20, 2025.
On GovTribe
See Cellsight Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors